There are no proven best peptides for thyroid health. No peptide has been shown in a randomized trial to treat an underactive thyroid, Hashimoto’s thyroiditis or Graves’ disease; a 2026 review found the evidence for peptides such as thymosin alpha-1 and BPC-157 is mainly lab and animal work.[10] The proven treatment for hypothyroidism is thyroid hormone replacement, usually levothyroxine.[1] The most important peptide-thyroid link is a safety one: GLP-1 drugs carry a boxed warning about thyroid C-cell tumors seen in rodents.[6]
For other longevity claims, see our longevity peptides hub.
Are thyroid hormones peptides?
Mostly not, which surprises many people. The thyroid system is a three-step chain:[2]
- TRH (thyrotropin-releasing hormone) is made in the brain’s hypothalamus. It is a true peptide: just three amino acids.
- TSH (thyroid-stimulating hormone) is released by the pituitary in response. It is a glycoprotein, a much larger protein with sugar chains.
- T4 and T3, the thyroid hormones themselves, are small molecules made from the amino acid tyrosine and iodine. They are not peptides in the usual sense.
The thyroid also makes calcitonin, a true peptide hormone that helps regulate calcium. So when products promise to “support the thyroid with peptides,” they are not replacing the hormones a failing thyroid stops making.
Evidence at a glance
| Peptide or drug | Evidence level | What was shown | FDA status | Our profile |
|---|---|---|---|---|
| Levothyroxine (not a peptide; standard care) | FDA-approved for this use | Replaces missing thyroid hormone[1] | Approved | — |
| TRH (protirelin) | FDA-approved (diagnostic, historical) | Used to test the pituitary-thyroid axis | Approved 1978; now discontinued[3] | — |
| Thyrotropin alfa (recombinant TSH; a glycoprotein) | FDA-approved for a narrow use | Used in thyroid cancer follow-up | Approved 1998[4] | — |
| Calcitonin salmon | FDA-approved, not for thyroid disease | Bone conditions such as Paget’s disease | Approved 1986[5] | — |
| Thymosin alpha-1 | Animal or lab only (for thyroid) | No thyroid-focused trials[10] | Not approved[11] | Thymosin alpha-1 |
| BPC-157 | Animal or lab only | No thyroid trials[10] | Not approved[11] | BPC-157 |
| Epitalon, thymalin and “bioregulators” | No evidence, marketing only | No controlled thyroid trials | Not approved | Epitalon, Thymalin |
What actually treats thyroid disease
- Underactive thyroid (hypothyroidism), including Hashimoto’s: the American Thyroid Association recommends levothyroxine as the standard treatment, with the dose adjusted using blood tests of TSH.[1]
- Overactive thyroid (hyperthyroidism), including Graves’ disease: treated with antithyroid medicines, radioactive iodine or surgery, chosen with an endocrinologist.
- Thyroid nodules and cancer: evaluated with ultrasound and sometimes a needle biopsy; cancer care may include surgery, radioactive iodine and follow-up testing with recombinant TSH.[4]
Getting the most from levothyroxine
Many people who look for a thyroid peptide feel their thyroid medicine is not working well. Often the problem is how the pill is taken. The levothyroxine label gives clear instructions:[12]
- Timing: take it once a day on an empty stomach, half an hour to an hour before breakfast.
- Spacing: take it at least 4 hours apart from products that block absorption, such as calcium carbonate, iron (ferrous sulfate) and some phosphate binders.
- Patience: the full effect may take 4 to 6 weeks, and adults usually have TSH rechecked 6 to 8 weeks after any dose change.
- Testing: stop biotin supplements at least 2 days before thyroid blood tests, because biotin can give falsely abnormal results.
- Pregnancy: higher doses may be needed, so tell your doctor as soon as you are pregnant.
The label also carries a boxed warning: thyroid hormone should not be used for weight loss, because doses above what the body needs can cause serious or life-threatening toxicity.[12]
The GLP-1 thyroid warning
Semaglutide, tirzepatide and other GLP-1 drugs carry a boxed warning. In rodents, semaglutide caused thyroid C-cell tumors at doses similar to human exposure. It is unknown whether it causes these tumors, including medullary thyroid carcinoma (MTC), in people. Wegovy must not be used by anyone with a personal or family history of MTC or with multiple endocrine neoplasia type 2 (MEN 2).[6]
Human studies are mixed:
- French national study (2023): in 2,562 people with thyroid cancer compared with 45,184 controls, 1 to 3 years of GLP-1 drug use was linked to a higher risk of all thyroid cancer (hazard ratio 1.58) and medullary thyroid cancer (1.78).[7]
- Scandinavian cohort (2024): among 145,410 GLP-1 users followed for about 3.9 years, thyroid cancer rates were similar to those of people taking another diabetes drug class (hazard ratio 0.93). The results ruled out more than about a 31% relative increase.[8]
Observational studies can be skewed by extra thyroid testing in people on these drugs. Our semaglutide cancer risk guide reviews the full picture.
GLP-1 drugs and levothyroxine
Oral semaglutide slows stomach emptying, which can change how other pills are absorbed. In a drug interaction study, taking levothyroxine with semaglutide tablets raised total thyroxine exposure by 33%. The label advises monitoring when combining it with drugs that need careful dosing.[9] If you take levothyroxine and start a GLP-1 drug, ask whether to recheck your thyroid levels.
Unproven “thyroid peptides”
Several peptides are marketed online for Hashimoto’s, fatigue or “thyroid support”:
- Thymosin alpha-1 and thymosin beta-4 (TB-500) for immune balance
- BPC-157 for inflammation
- Growth hormone secretagogues for energy
- Khavinson-style “bioregulators,” short peptides claimed to target specific glands
A 2026 review of peptide use in thyroid disease found that the available data come mainly from preclinical, mechanistic and early exploratory reports, not large randomized trials with thyroid outcomes, and called for well-designed trials.[10] FDA lists thymosin alpha-1, BPC-157, TB-500 and epitalon among bulk substances whose compounding nominations raised safety concerns.[11]
For background, see our Khavinson peptide bioregulators guide and thymosin alpha-1 vs LL-37.
How strong is the evidence?
To judge new claims yourself, see how to read peptide research and why animal peptide studies don’t translate.
Questions to ask your endocrinologist
- Is my thyroid dose right, based on my latest TSH?
- Could another condition explain my symptoms?
- Is a GLP-1 drug safe for me given my thyroid and family history?
- Which supplements could interfere with my thyroid medicine?
- Am I taking my levothyroxine at the right time and spaced from other pills?
For more on talking with your clinician, see how to talk to your doctor about peptides.
